Background: Susceptibility-based MRI offers a unique opportunity to study neurological diseases such as multiple sclerosis (MS). In this work, we assessed a three-dimensional segmented echo-planar-imaging (3D-EPI) sequence to rapidly acquire high-resolution T 2 * -weighted and phase contrast images of the whole brain. We also assessed if these images could depict important features of MS at clinical field strength, and we tested the effect of a gadolinium-based contrast agent (GBCA) on these images. Materials and methods: The 3D-EPI acquisition was performed on four healthy volunteers and 15 MS cases on a 3T scanner. The 3D sagittal images of the whole brain were acquired with a voxel size of 0.55 × 0.55 × 0.55 mm 3 in less than 4 minutes. For the MS cases, the 3D-EPI acquisition was performed before, during, and after intravenous GBCA injection. Results: Both T 2 * -weighted and phase-contrast images from the 3D-EPI acquisition were sensitive to the presence of lesions, parenchymal veins, and tissue iron. Conspicuity of the veins was enhanced when images were obtained during injection of GBCA. Conclusions: We propose this rapid imaging sequence for investigating, in a clinical setting, the spatiotemporal relationship between small parenchymal veins, iron deposition, and lesions in MS patient brains.
Introduction
Susceptibility-based magnetic resonance imaging (MRI) contrast (referring both to contrast generated by T 2 * signal loss and phase accumulation from non-refocused gradient echoes) enables the study of fine anatomical details within gray and white matter. 1 Susceptibility contrast is also extremely useful to study neuronal activation, 2 image parenchymal veins, 3 detect hemorrhage, 4 or reveal calcification. 5 In addition, T 2 * can be used to gauge tissue iron. 6 and could potentially assess myelin content. 7 Therefore, susceptibility-based imaging is an attractive MRI tool for characterizing in vivo brain tissue changes caused by neurological diseases. This is of particular interest in multiple sclerosis (MS), where it has been already applied at various field strengths to characterize veins inside white matter (WM) lesions, 8, 9 cortical lesions, 10, 11 iron-laden macrophages at the edge of certain lesions, 10, 12 iron deposition inside deep gray nuclei, 13, 14 and the severity of parenchymal tissue destruction. 15 However, in most of these studies T 2 * imaging was performed using a conventional spoiled (two-or threedimensioanl (3D)) gradient echo (GRE) sequence, which requires a compromise between high isotropic resolution and whole-brain coverage to avoid excessively long scan times. As a result, high resolution imaging is typically limited to the supratentorial brain, thus neglecting the brainstem and cerebellum, both of which are often severely affected in MS. 16, 17 If whole brain coverage is desired, the use of small isotropic voxel dimensions (<1 mm 3 in volume) is usually avoided; high-resolution is achieved in one plane only (typically the axial plane), whereas resolution in the slice direction remains relatively low (usually 2 to 4 mm). Such anisotropic voxels render fine anatomical details related to the disease difficult to visualize in three planes, and these details can even be missed due to the partial volume effect caused by the use of large slice thicknesses. More broadly, these limitations hamper the optimal use of susceptibility imaging in a clinical environment, where acquisition speed and whole-brain coverage are required.
Recently, a different acquisition strategy has been introduced at ultra-high field, allowing fast, high-resolution susceptibility imaging of the whole brain. 18 In a manner analogous to using an echo train to accelerate spin echo sequences (so-called fast or turbo spin echo), a threedimensional segmented echo-planar-imaging (3D-EPI) sequence can be used to accelerate GRE imaging. Using such 3D-EPI in healthy brains at 7 T, T 2 * -weighted and phase contrast with high anatomic fidelity, and a considerable gain in volume coverage relative to conventional GRE images, were obtained without sacrificing scan time. 18 Therefore, in this work, we investigated whether 3D-EPI is feasible at clinical field strength (3 T) and can provide useful T 2 * -weighted and phase contrast in the evaluation of MS. Because the relationship of MS plaques to parenchymal veins is an active area of research, 19, 20 we also tested the effect of gadolinium-based contrast agent (GBCA) on the conspicuity of veins in 3D-EPI images obtained before, during, and after the injection of contrast agent.
Materials and methods
Imaging was performed on four healthy participants (4 men, age 37±6 years) and 15 MS cases (10 men, 5 women, age 43±13 years), all of whom gave written, informed consent to participate in an Institutional Review Boardapproved protocol. 3D-EPI was acquired using a 3 T MRI system (Philips Healthcare, Best, The Netherlands) with the manufacturer's eight-channel receive-only head coil and body transmit coil. An automated whole-brain firstorder shimming procedure provided by the manufacturer was performed before acquisition. The 3D-EPI acquisition used 0.55 × 0.55 × 0.55 mm 3 voxels (0.17 mm 3 voxel volume) covering the whole brain (336 slices). This acquisition relied on the manufacturer's segmented EPI readout using a Cartesian interleaved k-space trajectory and an EPI factor of 15 lines per excitation. Acquisition was 3D and performed in the sagittal plane with a parallel imaging (Sensitivity Encoding for Fast MRI, also called SENSE) factor of 2 in both left-right (i.e. slice-encoding) and anterior-posterior (i.e. phase-encoding) directions. A fat suppression pre-pulse removed the artifacts resulting from shifted fat signal (water-fat shift of 9.6 mm here).This was achieved using a fat-selective binomial spatial and spectral saturation pulse from the manufacturer ('Proset 1331'). Other parameters were: field of view = 220 (anteriorposterior) × 220 (foot-head) × 185 (left-right) mm 3 , flip angle = 10°, repetition time = 54 ms, echo time = 29 ms, number of slices = 336, bandwidth in the readout direction = 490 Hz/pixel, bandwidth in the phase-encoding direction = 27 Hz/pixel. For improved signal-to-noise ratio (SNR), the sequence was acquired twice (number of excitations = 2), giving a total scan time under 4 min.
To test the effect of GBCA on venous contrast, the 3D-EPI acquisition was repeated for all 15 MS cases at three different times during the scanning: before, during and, approximately 15 min after GBCA injection. The GBCA was a single dose of gadopentetate dimeglumine (Magnevist; Bayer Healthcare, Leverkusen, Germany) or gadobutrol (Gadavist; Bayer Healthcare, Leverkusen, Germany) injected intravenously over 60 s. The infusion of GBCA was started simultaneously with the second 3D-EPI acquisition using a power injector (MEDRAD, Warrendale, PA).
Magnitude and phase images were collected as DICOM data produced by the MRI scanner. All analyses done on the magnitude images were performed using Matlab (The MathWorks, Natick, MA) and MIPAV (Medical Image Processing, Analysis & Visualization, NIH). For the phase images, an automatic analytical phase unwrapping was employed, as described by Schofield and Zhu. 21 Following phase unwrapping, large background gradients were removed by performing Gaussian filtering with a filter size of 32 pixels and full width at half maximum of 8 pixels. 22 To measure the SNR of the magnitude 3D-EPI images, two consecutive acquisitions were performed on the four healthy participants. Using the dual-acquisition subtraction method, 23 the SNR was calculated as:
where SI 1 is the mean intensity in the region-of-interest (ROI) on the first magnitude image, and SD 1-2 is the standard deviation in the ROI on the subtraction magnitude image. A transverse slice passing though the genu and splenium of the corpus callosum of the healthy subjects was selected and a 160 × 160 pixel ROI centered inside the brain parenchyma was used for calculating the SNR.
To measure contrast-to-noise ratio (CNR) between two different types of brain tissue, the mean intensities of the two tissues of interest (SI 1 for tissue 1 and SI 2 for tissue 2) were used as input in the following equation:
For the CNR lesion-WM , ROIs were drawn manually for the lesions detected on a transverse slice passing though the genu and splenium of the corpus callosum. A nearby ROI with normal appearing WM was also drawn on this slice. For CNR GP-WM and CNR DN-WM , ROIs were drawn on a sagittal slice where both the globus pallidus (GP) and the dentate nucleus (DN) were visible. A region of normal appearing deep WM was also drawn on this slice. For the CNR vein-WM , a minimum intensity projection (mIP) was first performed across 15 slices (i.e. 7.5 mm) along the head-foot direction at the level of the corpus callosum for the before, duringand after injection acquisitions. A mIP image of the preinjection acquisition revealing the deep medullary veins of the WM was selected, onto which a ROI primarily containing small veins was drawn. A nearby ROI without any apparent blood vessels was also drawn on the same mIP image. To quantify the effect of GBCA on the conspicuity of small parenchymal veins, the same ROIs were applied to the mIP images of the during and after injection acquisitions. All the CNR calculations were performed across the 15 MS cases. Mean values and standard deviation values across the 15 cases are mentioned in the Results section.
A count of the lesions with and without a central vein was also performed for the 15 MS cases using the same transverse slice as the one previously selected for CNR lesion-WM calculations. Finally, lesions with a hypointense rim on magnitude image were counted when examining all the brain slices of the 15 MS patients.
Results

3D-EPI measurements performed in healthy volunteers
yielded an SNR of 9.4 ± 1.0 (mean ± standard deviation across n = 4 volunteers). In MS cases, the 3D-EPI T 2 *weighted images displayed WM lesions (red arrows in Figure 1 ) as hyperintensities (CNR lesion-WM = 0.14 ± 0.04). In our MS cohort, only one patient showed hyperintense lesions with a hypointense rim (n = 3 lesions), most likely attributable to iron-loaded macrophages. 10 Parenchymal veins appeared as hypointense structures (CNR vein-WM = −0.09 ± 0.05) with a round or linear shape, depending on their orientation relative to the visualization plane. Some of the deep gray matter nuclei, particularly globus pallidus and dentate nucleus (green arrows in Figure 1 ), also appeared hypointense (CNR GP-WM = −0.16 ± 0.07 and CNR DN-WM = −0.17 ± 0.11). As expected for a gradient-echo based acquisition, 3D-EPI images also suffered from some signal losses in brain areas close to air/tissue interfaces, especially the paranasal sinuses and mastoid air cells (blue arrows in Figure 1 ).
Phase contrast images derived from the 3D-EPI acquisition provided complementary information about the disease ( Figure 2 ). Some lesions detected on T 2 * -weighted images appeared hypointense on the phase contrast (more paramagnetic relative to WM; Figure 2(B) ), whereas others appeared isointense to WM with a hypointense rim (paramagnetic rim; Figure 2(A) ).
The effect of GBCA injection on the conspicuity of small veins is shown in Figure 3 . Comparison of the before, during, and after GBCA mIP images demonstrates that the conspicuity of the small deep medullary veins was maximal when the 3D-EPI acquisition occurred during injection (CNR vein-WM = −0.19 ± 0.07, mean ± standard deviation, n = 4 healthy volunteers) as compared with the acquisition before (CNR vein-WM = −0.09 ± 0.05) and ~15 min after injection (CNR vein-WM = −0.10 ± 0.05). Note that the use of GBCA allowed for clear delineation of central veins within lesions, which were poorly visible prior to contrast injection. These central veins were detected inside many WM lesions, especially in the periventricular and deep WM areas (Figure 4 ). In those WM areas, up to 96% of the lesions (123 out of 128 lesions) detected in our MS cohort depicted a central vein. Note that this co-localization of veins and MS lesions could also be observed in the cerebellum (Figure 5 ).
Discussion
This study describes the use of a fast 3D segmented EPI acquisition that provides whole-brain, high-resolution (voxel size of 0.55 × 0.55 × 0.55 mm 3 ) T 2 * -weighted and phase images at 3 T in less than 4 min. This acquisition was developed for routine clinical scanning using the manufacturer's 3D-EPI sequence and standard phased-array receiver (eight-channel head coil).
From a technical standpoint, the use of a 3D-EPI sequence, instead of the more conventional GRE, offers substantial advantages. As recently demonstrated, 18 the 3D segmented EPI acquisition allows faster acquisition speeds, greater brain coverage, and higher SNR than standard GRE. Moreover, the use of high isotropic resolution with the 3D-EPI acquisition enables the visualization of fine anatomical details as well as the reformatting of images in any plane. Although this is an EPI-based acquisition, we did not notice significant distortions in most of the brain, most likely due to the segmented readout. Only a slight distortion (maximum ~4-5 mm) was observed at some of the brain edges.
From a clinical perspective, this 3D-EPI acquisition could be used to study in vivo the relationship between WM lesions and parenchymal vasculature, since it can depict both features on the same image. Such study could assess the role of parenchymal veins in the pathogenesis of MS lesions, which might act as a conduit for the inflammatory cells that trigger their development and growth. 24 , 25 Note that to further improve the detection of both veins and WM lesions on the same image, one could also combine our 3D EPI acquisition with a 3D FLAIR to produce the so-called FLAIR * contrast. 26, 27 The first MRI report of co-localization of MS lesions and veins was published by Tan and colleagues in 2000 and used a conventional GRE acquisition at low field strength (1.5 T). 8 Since then, several studies have reproduced that finding while optimizing the imaging protocols for use at higher field strengths (3 T and 7 T). 19, 28, 29 Based on these reports, it has been suggested that the diagnostic criteria for MS might be refined by including the detection, by MRI, of a central vein inside lesions. 20 Whether detection of such veins will increase diagnostic accuracy for MS still awaits further investigation, 30 but the 3D-EPI technique could be used to address this question. Indeed, as demonstrated here, the 3D-EPI acquisition can be performed on a 3 T MRI platform operating in a clinical environment, thus making it appropriate for large-scale, longitudinal studies of patients with various neurological conditions mimicking the MRI presentation of MS.
Another important clinical feature of the 3D-EPI acquisition concerns its extreme sensitivity to non-heme iron present in the brain parenchyma. Indeed, both T 2 * -weighted and phase contrast EPI are able to detect lesions with a hypointense rim. Initially reported at 7 T, 31 this type of lesion has been recently characterized ex vivo by combining MRI and histology, 10 and its hypointense rim has been attributed to iron-laden macrophages and microglia. Longitudinal observations with the 3E EPI technique could help to further understand differences in the pathogenesis of this type of lesion in comparison to other MS lesions. As illustrated here for the globus pallidus and dentate nucleus, 3D-EPI images can also be used to track brain areas (including putamen, caudate nucleus, and thalamus) known to experience non-heme iron deposition, which may be accentuated in MS. 13 However, a current limitation of our 3D-EPI protocol is that it allows data acquisition at only one echo time, meaning that the presence of iron cannot be evaluated quantitatively from magnitude images via T 2 * relaxationtime mapping. 13 A solution would be to use instead quantitative susceptibility mapping (QSM), which has recently emerged as a method to identify and quantify iron A and B) .The third case also shows two lesions with a central vein (red arrows inside magnified boxes of C), but one lesion (the largest one) also displays a hypointense rim at its edge. deposition in deep gray nuclei of MS brains. 32 Since the calculation of these susceptibility maps relies on solving an inverse problem from gradient-echo phase data, it can in principle be applied to the 3D-EPI phase images in a straightforward manner.
Conclusions
This study describes the use of a rapid, ultra-highresolution (isotropic voxels of 0.17 mm 3 volume) imaging protocol in MS patients on a clinical 3 T scanner using a manufacturer-provided pulse sequence. Whole-brain coverage was achieved in less than 4 min, yielding T 2 *weighted and phase images via a 3D segmented EPI acquisition. These images are sensitive to MS lesions as well as to parenchymal veins and tissue iron. We tested the effect of gadolinium-based contrast agent by performing the acquisition during the injection of contrast and found that it further enhances the detection of small parenchymal veins. Thus, we propose to use this approach for investigating, on a large scale, the spatiotemporal relationship between parenchymal veins and lesions, as well as the development of lesions with a rim of iron-laden macrophages and the deposition of tissue iron in deep gray matter, that can occur in the brains of people with MS.
